143 related articles for article (PubMed ID: 26104439)
1. Antibodies: Computer-Aided Prediction of Structure and Design of Function.
Sevy AM; Meiler J
Microbiol Spectr; 2014 Dec; 2(6):. PubMed ID: 26104439
[TBL] [Abstract][Full Text] [Related]
2. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
3. ABodyBuilder: Automated antibody structure prediction with data-driven accuracy estimation.
Leem J; Dunbar J; Georges G; Shi J; Deane CM
MAbs; 2016 Oct; 8(7):1259-1268. PubMed ID: 27392298
[TBL] [Abstract][Full Text] [Related]
4. Ab initio structure prediction of the antibody hypervariable H3 loop.
Zhu K; Day T
Proteins; 2013 Jun; 81(6):1081-9. PubMed ID: 23255066
[TBL] [Abstract][Full Text] [Related]
5. Third generation antibody discovery methods: in silico rational design.
Sormanni P; Aprile FA; Vendruscolo M
Chem Soc Rev; 2018 Dec; 47(24):9137-9157. PubMed ID: 30298157
[TBL] [Abstract][Full Text] [Related]
6. Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.
Andrianov AM; Anishchenko IV
J Biomol Struct Dyn; 2009 Oct; 27(2):179-93. PubMed ID: 19583444
[TBL] [Abstract][Full Text] [Related]
7. Computational approaches for drug discovery.
Hung CL; Chen CC
Drug Dev Res; 2014 Sep; 75(6):412-8. PubMed ID: 25195585
[TBL] [Abstract][Full Text] [Related]
8. Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires.
DeKosky BJ; Lungu OI; Park D; Johnson EL; Charab W; Chrysostomou C; Kuroda D; Ellington AD; Ippolito GC; Gray JJ; Georgiou G
Proc Natl Acad Sci U S A; 2016 May; 113(19):E2636-45. PubMed ID: 27114511
[TBL] [Abstract][Full Text] [Related]
9. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
Wang T; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
[TBL] [Abstract][Full Text] [Related]
10. In-silico approaches to multi-target drug discovery : computer aided multi-target drug design, multi-target virtual screening.
Ma XH; Shi Z; Tan C; Jiang Y; Go ML; Low BC; Chen YZ
Pharm Res; 2010 May; 27(5):739-49. PubMed ID: 20221898
[TBL] [Abstract][Full Text] [Related]
11. Current insights into computer-aided immunotherapeutic design strategies.
Cai Z; Zhang G; Zhang X; Liu Y; Fu X
Int J Immunopathol Pharmacol; 2015 Sep; 28(3):278-85. PubMed ID: 26091813
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in automated protein design and its future challenges.
Setiawan D; Brender J; Zhang Y
Expert Opin Drug Discov; 2018 Jul; 13(7):587-604. PubMed ID: 29695210
[TBL] [Abstract][Full Text] [Related]
13. Predicting antibody complementarity determining region structures without classification.
Choi Y; Deane CM
Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
[TBL] [Abstract][Full Text] [Related]
14. Robustification of RosettaAntibody and Rosetta SnugDock.
Jeliazkov JR; Frick R; Zhou J; Gray JJ
PLoS One; 2021; 16(3):e0234282. PubMed ID: 33764990
[TBL] [Abstract][Full Text] [Related]
15. [Current applications of high-throughput DNA sequencing technology in antibody drug research].
Yu X; Liu QG; Wang MR
Yao Xue Xue Bao; 2012 Mar; 47(3):322-31. PubMed ID: 22645755
[TBL] [Abstract][Full Text] [Related]
16. The role of experimental and computational structural approaches in 7TM drug discovery.
Topiol S; Sabio M
Expert Opin Drug Discov; 2015 Oct; 10(10):1071-84. PubMed ID: 26211671
[TBL] [Abstract][Full Text] [Related]
17. Accurate prediction for atomic-level protein design and its application in diversifying the near-optimal sequence space.
Fromer M; Yanover C
Proteins; 2009 May; 75(3):682-705. PubMed ID: 19003998
[TBL] [Abstract][Full Text] [Related]
18. Computer-aided drug design: time to play with novel chemical matter.
Barril X
Expert Opin Drug Discov; 2017 Oct; 12(10):977-980. PubMed ID: 28756685
[No Abstract] [Full Text] [Related]
19. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
20. OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding.
Pantazes RJ; Maranas CD
Protein Eng Des Sel; 2010 Nov; 23(11):849-58. PubMed ID: 20847101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
